Recombinant SARS-CoV-2 Spike protein, RBD (Receptor Binding Domain) encompassing amino acids 319-541. This protein corresponds to SARS-CoV-2 Variant B.1.617 originally identified in India, and contains mutations L452R and E484K. The construct contains a C-terminal Avi-Tag followed by a His-tag (6xHis). The protein was affinity purified. HiP indicates a high purity protein (>=90% pure) and less than 10% aggregation as measured by gel filtration. Constructs: Spike S1 RBD (B.1.617 Variant) (319-541-Avi-His) (SARS-CoV-2)
Immunogen Region
319-541
Tag
C-terminal Avi-His-tag
Formulation
8 mM phosphate pH 7.4, 110 mM NaCl, 2.2 mM KCl, 20% glycerol
Mutation
L452R, E484Q
Species
SARS-CoV-2
Notes
Avoid freeze/thaw cycles.
GenBank
MN908947
Mw(kda)
28 kDa + glycans
Synonyms
coronavirus, covid, covid-19, covid19, Sars-cov-2 RBD, sars cov 2 Spike, sarscov2, SARS-CoV-2 variant b1617, Lineage B.1.617, B1617 mutation, India coronavirus, SARS-CoV-2 India, India, India variant, 101156-1, 101156-2